Abstract:
One of the major endpointsto be considered while choosing glucose-lowering therapy is their impact on cardiovascular outcomes. As a corollary, the cardiovascular health assessment of a person with diabetes informs the choice of glucose-lowering treatment. The clinical aspects included in this bidirectional relationship are described in this review as the cardiovascular phenotype. Vital signs, cardiac autonomic function, myocardial health and coronary status influence, and are influenced by, choice of glucose-lowering therapy. Such therapy also has an impact on cerebrovascular and peripheral arterialhealth.These aspectsshouldbe considered while planning treatment for type 2 diabetes mellitus.
Page(s):
480-482
DOI:
DOI not available
Published:
Journal: Journal of Pakistan Medical Association, Volume: 66, Issue: 4, Year: 2016